List of Tables
Table 1. Computational Drug Discovery Market Trends
Table 2. Computational Drug Discovery Market Drivers & Opportunity
Table 3. Computational Drug Discovery Market Challenges
Table 4. Computational Drug Discovery Market Restraints
Table 5. Global Computational Drug Discovery Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Computational Drug Discovery Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Computational Drug Discovery Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Computational Drug Discovery Product Type
Table 9. Key Companies Time to Begin Mass Production of Computational Drug Discovery
Table 10. Global Computational Drug Discovery Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Drug Discovery as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Computational Drug Discovery Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Computational Drug Discovery Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Computational Drug Discovery Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Computational Drug Discovery Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Computational Drug Discovery Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Computational Drug Discovery Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Computational Drug Discovery Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Computational Drug Discovery Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Computational Drug Discovery Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Computational Drug Discovery Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Computational Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Computational Drug Discovery Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Computational Drug Discovery Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Computational Drug Discovery Sales Value by Region (2019-2024) & (%)
Table 27. Global Computational Drug Discovery Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Computational Drug Discovery Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Computational Drug Discovery Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Computational Drug Discovery Sales Value, (2025-2030) & (US$ Million)
Table 31. AMRI Basic Information List
Table 32. AMRI Description and Business Overview
Table 33. AMRI Computational Drug Discovery Products, Services and Solutions
Table 34. Revenue (US$ Million) in Computational Drug Discovery Business of AMRI (2019-2024)
Table 35. AMRI Recent Developments
Table 36. Charles River Basic Information List
Table 37. Charles River Description and Business Overview
Table 38. Charles River Computational Drug Discovery Products, Services and Solutions
Table 39. Revenue (US$ Million) in Computational Drug Discovery Business of Charles River (2019-2024)
Table 40. Charles River Recent Developments
Table 41. Schrödinger Basic Information List
Table 42. Schrödinger Description and Business Overview
Table 43. Schrödinger Computational Drug Discovery Products, Services and Solutions
Table 44. Revenue (US$ Million) in Computational Drug Discovery Business of Schrödinger (2019-2024)
Table 45. Schrödinger Recent Developments
Table 46. Evotec Basic Information List
Table 47. Evotec Description and Business Overview
Table 48. Evotec Computational Drug Discovery Products, Services and Solutions
Table 49. Revenue (US$ Million) in Computational Drug Discovery Business of Evotec (2019-2024)
Table 50. Evotec Recent Developments
Table 51. Bayers Basic Information List
Table 52. Bayers Description and Business Overview
Table 53. Bayers Computational Drug Discovery Products, Services and Solutions
Table 54. Revenue (US$ Million) in Computational Drug Discovery Business of Bayers (2019-2024)
Table 55. Bayers Recent Developments
Table 56. GVK Biosciences Basic Information List
Table 57. GVK Biosciences Description and Business Overview
Table 58. GVK Biosciences Computational Drug Discovery Products, Services and Solutions
Table 59. Revenue (US$ Million) in Computational Drug Discovery Business of GVK Biosciences (2019-2024)
Table 60. GVK Biosciences Recent Developments
Table 61. AstraZeneca Basic Information List
Table 62. AstraZeneca Description and Business Overview
Table 63. AstraZeneca Computational Drug Discovery Products, Services and Solutions
Table 64. Revenue (US$ Million) in Computational Drug Discovery Business of AstraZeneca (2019-2024)
Table 65. AstraZeneca Recent Developments
Table 66. BioDuro Basic Information List
Table 67. BioDuro Description and Business Overview
Table 68. BioDuro Computational Drug Discovery Products, Services and Solutions
Table 69. Revenue (US$ Million) in Computational Drug Discovery Business of BioDuro (2019-2024)
Table 70. BioDuro Recent Developments
Table 71. BOC Sciences Basic Information List
Table 72. BOC Sciences Description and Business Overview
Table 73. BOC Sciences Computational Drug Discovery Products, Services and Solutions
Table 74. Revenue (US$ Million) in Computational Drug Discovery Business of BOC Sciences (2019-2024)
Table 75. BOC Sciences Recent Developments
Table 76. Aris Pharmaceuticals Basic Information List
Table 77. Aris Pharmaceuticals Description and Business Overview
Table 78. Aris Pharmaceuticals Computational Drug Discovery Products, Services and Solutions
Table 79. Revenue (US$ Million) in Computational Drug Discovery Business of Aris Pharmaceuticals (2019-2024)
Table 80. Aris Pharmaceuticals Recent Developments
Table 81. ChemDiv Basic Information List
Table 82. ChemDiv Description and Business Overview
Table 83. ChemDiv Computational Drug Discovery Products, Services and Solutions
Table 84. Revenue (US$ Million) in Computational Drug Discovery Business of ChemDiv (2019-2024)
Table 85. ChemDiv Recent Developments
Table 86. RTI International Basic Information List
Table 87. RTI International Description and Business Overview
Table 88. RTI International Computational Drug Discovery Products, Services and Solutions
Table 89. Revenue (US$ Million) in Computational Drug Discovery Business of RTI International (2019-2024)
Table 90. RTI International Recent Developments
Table 91. XRQTC Basic Information List
Table 92. XRQTC Description and Business Overview
Table 93. XRQTC Computational Drug Discovery Products, Services and Solutions
Table 94. Revenue (US$ Million) in Computational Drug Discovery Business of XRQTC (2019-2024)
Table 95. XRQTC Recent Developments
Table 96. Pharmaron Basic Information List
Table 97. Pharmaron Description and Business Overview
Table 98. Pharmaron Computational Drug Discovery Products, Services and Solutions
Table 99. Revenue (US$ Million) in Computational Drug Discovery Business of Pharmaron (2019-2024)
Table 100. Pharmaron Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Computational Drug Discovery Downstream Customers
Table 104. Computational Drug Discovery Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Computational Drug Discovery Product Picture
Figure 2. Global Computational Drug Discovery Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Computational Drug Discovery Sales Value (2019-2030) & (US$ Million)
Figure 4. Computational Drug Discovery Report Years Considered
Figure 5. Global Computational Drug Discovery Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Computational Drug Discovery Revenue in 2023
Figure 7. Computational Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Structure-based Drug Design (SBDD) Picture
Figure 9. Ligand-based Drug Design (LBDD) Picture
Figure 10. Sequence-based Approaches Picture
Figure 11. Global Computational Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Computational Drug Discovery Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Oncological Disorders
Figure 14. Product Picture of Neurological Disorders
Figure 15. Product Picture of Immunological Disorders
Figure 16. Product Picture of Infectious Diseases
Figure 17. Product Picture of Others
Figure 18. Global Computational Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Computational Drug Discovery Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Computational Drug Discovery Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Computational Drug Discovery Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Computational Drug Discovery Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Computational Drug Discovery Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Computational Drug Discovery Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Computational Drug Discovery Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Computational Drug Discovery Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Computational Drug Discovery Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Computational Drug Discovery Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Computational Drug Discovery Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Computational Drug Discovery Sales Value (%), (2019-2030)
Figure 31. United States Computational Drug Discovery Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Computational Drug Discovery Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Computational Drug Discovery Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Computational Drug Discovery Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Computational Drug Discovery Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Computational Drug Discovery Sales Value by Application (%), 2023 VS 2030
Figure 37. China Computational Drug Discovery Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Computational Drug Discovery Sales Value by Type (%), 2023 VS 2030
Figure 39. China Computational Drug Discovery Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Computational Drug Discovery Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Computational Drug Discovery Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Computational Drug Discovery Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Computational Drug Discovery Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Computational Drug Discovery Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Computational Drug Discovery Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Computational Drug Discovery Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Computational Drug Discovery Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Computational Drug Discovery Sales Value by Application (%), 2023 VS 2030
Figure 49. India Computational Drug Discovery Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Computational Drug Discovery Sales Value by Type (%), 2023 VS 2030
Figure 51. India Computational Drug Discovery Sales Value by Application (%), 2023 VS 2030
Figure 52. Computational Drug Discovery Industrial Chain
Figure 53. Computational Drug Discovery Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
